Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lutz Harms

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Advances in Therapy|April 26, 2020
The Impact of Patient Support Programs on Adherence to Disease-Modifying Therapies of Patients with Relapsing-Remitting Multiple Sclerosis in Germany: A Non-Interventional, Prospective StudyFlorian Lenz, Lutz Harms
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 1, 2018
Fulminant rebound of relapsing-remitting multiple sclerosis after discontinuation of dimethyl fumarate: A case reportPeter Harmel, Frieder Schlunk, Lutz Harms
The Journal of Neuropsychiatry and Clinical Neurosciences|March 28, 2012
Cerebral amyloid angiopathy-related inflammation: a treatable cause of rapidly-progressive dementiaOliver Wengert, Lutz Harms, Eberhard Siebert
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 2, 2013
Posttraumatic bilateral hypertrophic olivary degenerationEberhard Siebert, Lutz Harms, Martin Herbst
Journal of Neuroimmunology|July 23, 2015
Toxoplasma gondii seropositivity is negatively associated with multiple sclerosisFrauke Stascheit, Friedemann Paul, Lutz Harms, et al.
Archives of Neurology|September 13, 2006
Distribution and outcome of symptomatic stenoses and occlusions in patients with acute cerebral ischemiaChristian Weimar, Michael Goertler, Lutz Harms, et al.
BMJ Case Reports|June 21, 2011
Skin reactions after intramuscular injection of Botulinum toxin A: a rare side effectNorbert Brüggemann, Lien Dögnitz, Lutz Harms, et al.
Journal of Neurology|August 9, 2017
High prevalence of neuronal surface autoantibodies associated with cognitive deficits in cancer patientsCarsten Finke, Frederik Bartels, Alva Lütt, et al.
Neurology|February 27, 2014
Author responseHagen Kunte, Felix Schmidt, Jan Hoffmann, et al.
Journal of Clinical Apheresis|May 10, 2017
A prospective study comparing tryptophan immunoadsorption with therapeutic plasma exchange for the treatment of chronic inflammatory demyelinating polyneuropathyIna Lieker, Torsten Slowinski, Lutz Harms, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Advances in Therapy|April 26, 2020
The Impact of Patient Support Programs on Adherence to Disease-Modifying Therapies of Patients with Relapsing-Remitting Multiple Sclerosis in Germany: A Non-Interventional, Prospective StudyFlorian Lenz, Lutz Harms
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 1, 2018
Fulminant rebound of relapsing-remitting multiple sclerosis after discontinuation of dimethyl fumarate: A case reportPeter Harmel, Frieder Schlunk, Lutz Harms
The Journal of Neuropsychiatry and Clinical Neurosciences|March 28, 2012
Cerebral amyloid angiopathy-related inflammation: a treatable cause of rapidly-progressive dementiaOliver Wengert, Lutz Harms, Eberhard Siebert
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 2, 2013
Posttraumatic bilateral hypertrophic olivary degenerationEberhard Siebert, Lutz Harms, Martin Herbst
Journal of Neuroimmunology|July 23, 2015
Toxoplasma gondii seropositivity is negatively associated with multiple sclerosisFrauke Stascheit, Friedemann Paul, Lutz Harms, et al.
Archives of Neurology|September 13, 2006
Distribution and outcome of symptomatic stenoses and occlusions in patients with acute cerebral ischemiaChristian Weimar, Michael Goertler, Lutz Harms, et al.
BMJ Case Reports|June 21, 2011
Skin reactions after intramuscular injection of Botulinum toxin A: a rare side effectNorbert Brüggemann, Lien Dögnitz, Lutz Harms, et al.
Journal of Neurology|August 9, 2017
High prevalence of neuronal surface autoantibodies associated with cognitive deficits in cancer patientsCarsten Finke, Frederik Bartels, Alva Lütt, et al.
Neurology|February 27, 2014
Author responseHagen Kunte, Felix Schmidt, Jan Hoffmann, et al.
Journal of Clinical Apheresis|May 10, 2017
A prospective study comparing tryptophan immunoadsorption with therapeutic plasma exchange for the treatment of chronic inflammatory demyelinating polyneuropathyIna Lieker, Torsten Slowinski, Lutz Harms, et al.
Pageof 9